Showing results (271-280 of 321) with videos related to
Sort By:
Pageof 33
Circulation|December 28, 2018
Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary InterventionAlexander C Fanaroff, Pearl Zakroysky, Daniel Wojdyla, et al.Critical Pathways in Cardiology|September 8, 2021
The Impact of American College of Cardiology Chest Pain Center Accreditation on Guideline Recommended Acute Myocardial Infarction ManagementW Frank Peacock, Phillip D Levy, Deborah B Diercks, et al.Circulation. Cardiovascular Interventions|May 31, 2015
Cluster-randomized clinical trial examining the impact of platelet function testing on practice: the treatment with adenosine diphosphate receptor inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome prospective open label antiplatelet therapy studyTracy Y Wang, Timothy D Henry, Mark B Effron, et al.JAMA Cardiology|November 14, 2019
Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical TrialAlexander C Fanaroff, Eric D Peterson, Lisa A Kaltenbach, et al.JAMA Cardiology|April 27, 2017
Association of US Centers for Medicare and Medicaid Services Hospital 30-Day Risk-Standardized Readmission Metric With Care Quality and Outcomes After Acute Myocardial Infarction: Findings From the National Cardiovascular Data Registry/Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the GuidelinesAmbarish Pandey, Harsh Golwala, Hurst M Hall, et al.JAMA Cardiology|March 5, 2020
Agreement and Accuracy of Medication Persistence Identified by Patient Self-report vs Pharmacy Fill: A Secondary Analysis of the Cluster Randomized ARTEMIS TrialAlexander C Fanaroff, Eric D Peterson, Lisa A Kaltenbach, et al.Circulation. Cardiovascular Quality and Outcomes|July 21, 2020
Improving Cardiovascular Drug and Device Development and Evidence Through Patient-Centered Research and Clinical Trials: A Call to Action From the Value in Healthcare Initiative's Partnering With Regulators Learning CollaborativeJohn J Warner, Hannah L Crook, Karley M Whelan, et al.American Heart Journal|May 16, 2016
Comparison of performance on Hospital Compare process measures and patient outcomes between hospitals that do and do not participate in Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The GuidelinesRobin Mathews, Gregg C Fonarow, Shuang Li, et al.American Heart Journal|June 15, 2016
Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): A multicenter, cluster-randomized trial of P2Y12 receptor inhibitor copayment reduction after myocardial infarctionJacob A Doll, Tracy Y Wang, Niteesh K Choudhry, et al.Circulation|February 10, 2012
Admission international normalized ratio levels, early treatment strategies, and major bleeding risk among non-ST-segment-elevation myocardial infarction patients on home warfarin therapy: insights from the National Cardiovascular Data RegistrySumeet Subherwal, Eric D Peterson, Anita Y Chen, et al.Pageof 33